Valeant Pharma reports quarterly loss, to change name to Bausch Health

Valeant Pharmaceuticals reported first-quarter loss compared with a year-ago profit and said on Tuesday it would change its name to Bausch Health Companies.

Net loss attributable to the company was at $2.69 billion, or $7.68 per share, in the quarter ended March 31, compared with a profit of $628 million, or $1.79 per share, a year earlier.

Total revenues fell 5.4 percent to $1.96 billion.

Source link

Leave a Reply

Your email address will not be published.